Fecal screenings cut colorectal cancer mortality 33%: Study

Fecal immunochemical tests can reduce colorectal cancer mortality rates by 33%, according to a July 19 study published in JAMA Network Open.

Advertisement

Fecal tests also result in a 42% reduction in deaths from left colon and rectal cancers, according to an Aug. 13 Medscape report. 

Researchers compared 1,103 adults who had died of colorectal cancer between 2011 and 2017, with 9,608 matched, randomly selected people who were alive and free of the disease. 

In a regression analysis, completing one or more FIT screenings was associated with a 33% lower risk for colorectal cancer death overall.

The benefits of FIT screening saw significant mortality reductions of 63% in non-Hispanic Asian, 42% in non-Hispanic Black, and 29% in non-Hispanic White individuals, according to the report. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • OSF HealthCare Saint Anthony Medical Center in Rockford, Ill., has added Tarik Firozi, MD, according to an April 6 report…

  • Miami-based Gastro Health has finalized a partnership with Digestive Disease Physicians, an Alexandria, Va.-based gastroenterology practice, according to an April…

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

Advertisement

Comments are closed.